Lilly’s Jaypirca shows positive results in phase 3 trial
12th August 2025 Uncategorised 0
Pirtobrutinib meets primary endpoint in CLL/SLL study

More: Lilly’s Jaypirca shows positive results in phase 3 trial
Source: News
Pirtobrutinib meets primary endpoint in CLL/SLL study

More: Lilly’s Jaypirca shows positive results in phase 3 trial
Source: News
© 1994 - 2026 B.M. Pharmaceuticals